Skip to main content

Research Repository

Advanced Search

THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2): A SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF METOCLOPRAMIDE FOR PREVENTION OF PNEUMONIA AFTER STROKE

Mhlanga, I; Roffe, C; Warusevitane, A; Smith, C; Dixit, A; Sprigg, N; Ogollah, R; Sim, J; Jowett, S; Havard, D; Kurlak, L; Ward, R; Palmer, J; Thomson, M; Latulipe, C; Woodhouse, L; Bath, P

Authors

I Mhlanga

A Warusevitane

C Smith

A Dixit

N Sprigg

R Ogollah

J Sim

S Jowett

D Havard

L Kurlak

R Ward

J Palmer

M Thomson

C Latulipe

L Woodhouse

P Bath



Citation

Mhlanga, I., Roffe, C., Warusevitane, A., Smith, C., Dixit, A., Sprigg, N., …Bath, P. (2024). THE METOCLOPRAMIDE FOR AVOIDING PNEUMONIA AFTER STROKE (MAPS-2): A SINGLE-BLIND RANDOMIZED CONTROLLED TRIAL OF METOCLOPRAMIDE FOR PREVENTION OF PNEUMONIA AFTER STROKE. International Journal of Stroke, 19(2), 24-24

Journal Article Type Meeting Abstract
Conference Name 16th World Stroke Congress
Conference Location Abu Dhabi, UAE
Acceptance Date Oct 1, 2024
Publication Date 2024-10
Deposit Date Feb 7, 2025
Journal International Journal of Stroke
Print ISSN 1747-4930
Publisher SAGE Publications
Peer Reviewed Peer Reviewed
Volume 19
Issue 2
Article Number O046
Pages 24-24
Public URL https://keele-repository.worktribe.com/output/1072797
Publisher URL https://journals.sagepub.com/doi/full/10.1177/17474930241274956


You might also like



Downloadable Citations